Chardan Capital Initiates Coverage On MannKind with Buy Rating, Announces Price Target of $10

Benzinga · 2d ago
Chardan Capital analyst Andreas Argyrides initiates coverage on MannKind (NASDAQ:MNKD) with a Buy rating and announces Price Target of $10.